The overall listing of new medicines has been invested in 7.4 billion My stake betting appyuan Stake Sports Bettinginto the second largest pharmaceutical group in China
Release time: 2009-10-22 & nbsp & nbsp & nbsp Source:
Shanghai Medicine、Shangxian Medicine、Chinese and Western Medicine Recently issued an announcement，Announce the major asset reorganization plan，Including three transactions: (1) Shanghai Pharmaceutical absorbs and merged Shangshi Pharmaceutical and Chinese and Western medicines，(2) Shanghai Pharmaceutical Group issued shares to buy assets，(3) Shanghai Pharmaceuticals raised funds to issue shares to Shanghai in Shanghai、and buy medical assets with these funds。
After the reorganization is completed，Shanghai state -owned assets will form a unified stake betting apppharmaceutical industry resource integration platform，The total assets of the new medicine will jump from 8 billion yuan My stake sports betting appstake betting appto 22.3 billion yuan，Sales revenue will jump from 23 billion yuan to 30 billion yuan，Become the second largest domestic pharmaceutical group after the Sinopharm Group。
The above three transactions jointly constitute this major asset reorganization.，Among them, no need to be approved or approved by any matter，Then this major asset reorganization does not take effect from the beginning，The relevant transactions of this major asset reorganization still requires the approval or approval of the shareholders meeting of each company and the relevant government departments。
The purpose and significance of this major asset reorganization lies in，Create a single listing platform，Basically realized the overall listing of the stake betting apppharmaceutical industry of Shangshi Group and the Pharmaceutical My stake betting appGroup，Create a complete pharmaceutical industry chain。Then enhance the core competitiveness of Shanghai medicine，The synergy effect of realizing industrial resource integration，and rely on the capital market to achieve leapfrog development，Basically solve the problem of competition in the industry，Standardize the operation of listed companies。
